Skip to main content
Fig. 7 | Journal of Pharmaceutical Health Care and Sciences

Fig. 7

From: Clinical relevance between sodium-glucose co-transporter 2 inhibitors and lipid profiles in Asian patients with type 2 diabetes mellitus: a systematic review with a meta-analysis of randomized controlled trials

Fig. 7

Relationship between SGLT2is and changes in the LDL-C/HDL-C ratio. Abbreviations: CANA, canagliflozin; LUSEO, luseogliflozin; SGLT2i, sodium-glucose co-transporter 2 inhibitor; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CI, confidence interval; SD, standard deviation.

Back to article page